Sri Jayadeva Institute of Cardiovascular Sciences and Research, is headquartered in Bengaluru is a tertiary care autonomous institute run by the Government of Karnataka, in Bengaluru, Mysuru and Kalaburagi.

During the past decade, Sri Jayadeva Institute of Cardiovascular Sciences and Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sri Jayadeva Institute of Cardiovascular Sciences and Research" #1 sponsor was "Medtronic Cardiac Surgery" with 1 trials, followed by "Meril Life Sciences Pvt. Ltd." with 1 trials sponsored, "NYU Langone Health" with 1 trials sponsored, "Sheri Kashmir Institute of Medical Sciences" with 1 trials sponsored and "Spectranetics Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sri Jayadeva Institute of Cardiovascular Sciences and Research" #1 collaborator was "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "CBCC-VIBGYOR Research Pvt. Ltd." with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Duke University" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Sri Jayadeva Institute of Cardiovascular Sciences and Research" are "Coronary Artery Disease" (3 trials), "Arrhythmogenic Cardiomyopathy" (1 trials), "Arrhythmogenic Right Ventricular Cardiomyopathy" (1 trials), "Arrhythmogenic Right Ventricular Dysplasia" (1 trials) and "Arrhythmogenic Ventricular Cardiomyopathy" (1 trials). Many other conditions were trialed in "Sri Jayadeva Institute of Cardiovascular Sciences and Research" in a lesser frequency.

Most popular intervention types in "Sri Jayadeva Institute of Cardiovascular Sciences and Research" are "Device" (2 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "All study subjects will undergo sample collection for genetic testing." (1 trials), "Ambulatory ECG recording" (1 trials), "Cardiac EP study" (1 trials), "Cardiac MRI" (1 trials) and "ECG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sri Jayadeva Institute of Cardiovascular Sciences and Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Sri Jayadeva Institute of Cardiovascular Sciences and Research". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sri Jayadeva Institute of Cardiovascular Sciences and Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sri Jayadeva Institute of Cardiovascular Sciences and Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".